Showing 471-480 of 3315 results for "".
Surveying the Options for Treating Demodex
https://modernod.com/mod-issues/2022-july-aug/surveying-the-options-for-treating-idemodexi/38466/What’s available, what’s coming, and the attributes of each.The Need to Define Advocacy Within Optometry
https://modernod.com/topics/health-policy/the-need-to-define-advocacy-within-optometry/38678/Where major health-related organizations stand on the question of advocacy. Part two of a multi-part series.The Truth About Generic Drugs
https://modernod.com/topics/technology/the-truth-about-generic-drugs/37920/Generic and branded drugs may be more different than you—or your patients—realize.IOL Opacification
https://modernod.com/mod-issues/2022-sept/iol-opacification/38495/In cases of decreased vision due to IOL calcification, explantation is typically the best route.New Drugs and Delivery Options in Glaucoma
https://modernod.com/topics/glaucoma/new-drugs-and-delivery-options-in-glaucoma/38069/Many are in development.The Art and Science of Managing Post-LASIK Keratectasia
https://modernod.com/topics/contact-lenses/the-art-and-science-of-managing-post-lasik-keratectasia/38782/When to consider contact lenses versus surgical intervention for the best patient outcomes.Barriers to the Business of Myopia Management
https://modernod.com/topics/myopia/barriers-to-the-business-of-myopia-management/38054/Adopting a myopia management program requires a paradigm shift in your practice.Is it Glaucoma? Perimetry Cracked the Case
https://modernod.com/topics/glaucoma/is-it-glaucoma-perimetry-cracked-the-case/54303/Advanced imaging can be very useful, but don’t neglect this tried-and-true diagnostic tool when differentiating nonglaucomatous etiologies.Stratifying Glaucoma Risk and Stage
https://modernod.com/mod-issues/2023-jan-feb/stratifying-glaucoma-risk-and-stage/38550/Pivotal studies offer guidance on clinical decisions.Balancing Treatment Challenges
https://modernod.com/topics/ocular-surface/balancing-treatment-challenges/38630/A look into the management of a patient with primary open-angle glaucoma, Fuchs endothelial corneal dystrophy, dry AMD, and ocular surface disease.